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Although short-term outcomes in kidney transplantation
have improved dramatically, long-term survival remains a
major challenge. A key component of long-term, chronic
allograft injury in solid organ transplants is arteriosclerosis
characterized by vascular neointimal hyperplasia and
inflammation. Establishing a model of this disorder would
provide a unique tool not only to identify mechanisms of
disease but also to test potential therapeutics for late graft
injury. To this end, we utilized a mouse orthotopic renal
transplant model in which C57BL/6J (H-2b) recipients were
given either a kidney allograft from a completely mismatched
Balb/cJ mouse (H-2d) or an isograft from a littermate.
A unilateral nephrectomy was performed at the time of
transplant followed by a contralateral nephrectomy on
post-transplant day 7. Recipients were treated with daily
cyclosporine subcutaneously for 14 days and then studied
8 and 12 weeks post transplantation. Renal function was
significantly worse in allograft compared with isograft
recipients. Moreover, the allografts had significantly more
advanced tubulointerstitial fibrosis and profound vascular
disease characterized by perivascular leukocytic infiltration
and neointimal hyperplasia affecting the intrarenal blood
vessels. Thus, we describe a feasible and reproducible murine
model of intrarenal transplant arteriosclerosis that is useful to
study allograft vasculopathy.
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Despite impressive advances in the initial success rate and
short-term survival in clinical transplantation, as well as an
impressive body of knowledge of the pathogenesis of graft
failure, the rate of long-term graft survival has not
significantly improved.1–4 Transplant arteriosclerosis is re-
cognized as a significant long-term complication of renal and
nonrenal solid organ transplantation.5,6 Several studies have
indicated both immunologic and nonimmunologic factors
that result in endothelial injury and ultimately lead to
vascular inflammation, neointima formation, and progressive
luminal obstruction.7–10 Nevertheless, the exact underlying
pathophysiological events remain to be identified. Incom-
plete understanding of the molecular mechanisms of allograft
vasculopathy has hampered our efforts to overcome this
detrimental condition. A limited number of animal models
exist to study transplant arteriosclerosis, and none has been
described using mice in the context of kidney transplanta-
tion. Previous studies describing murine models of chronic
allograft nephropathy using various strain combinations have
not described intrarenal vascular lesions that resemble
human transplant arteriosclerosis.
This report describes a mouse orthotopic renal transplant
model with striking intrarenal vasculopathy that can be used
to study the underlying mechanism and potential therapeutic
targets of renal allograft–related vasculopathy.
RENAL FUNCTION IS WORSE IN ALLOGRAFTS
Animal survival and renal function was significantly worse in
the allograft recipients compared with the isograft recipients
(functional decline was significant in the allograft recipient
group starting at 3 weeks post transplantation) (Figure 1a
and b). In this model, the outcome of the surgery is highly
dependent on the technical skills of the microsurgeon
performing the procedure. Of 173 orthotopic kidney
transplants performed at our center, the overall survival rate
for all kidney transplants was B78%, with a follow-up of 60
days, much in line with other reported outcomes.11,12 These
survival data include all animals in which surgery was
performed, not just those that survived beyond a given time
point, and therefore represent routine, reproducible survival.
In all, 21% of the transplant animals died at less than 30 days
post transplantation. Reasons for loss of grafts included
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bleeding from vascular anastomotic site, graft hydronephro-
sis, and thrombosis. Importantly, there were no differences in
terms of technical failures between allografts and isografts.
Compared with the isograft recipients, proteinuria (measured
by urinary albumin/creatinine ratio) was higher (P-value
o0.05) at 8 and 12 weeks post transplantation in the
allograft recipient group (Figure 1c). These results confirmed
that mismatched renal allograft recipients develop impaired
renal function and proteinuria and reduced survival when
compared with isograft recipients.
ALLOGRAFT KIDNEYS DISPLAY INCREASED COLLAGEN
DEPOSITION, PERIVASCULAR INFILTRATE, AND
NEOINTIMAL HYPERPLASIA
Histological analysis revealed that isografts had better
preserved kidney architecture and normal intrarenal arteries
(Figure 2a and b, left panels) compared with allografts that
displayed increased fibrosis and intrarenal vascular disease
(Figure 2a and b, right panels). Semiquantitative analysis
revealed markedly higher amounts of interstitial collagen
deposition in the allografts at both 8 and 12 weeks post
transplantation (Figure 2c). Importantly, intrarenal blood
vessels had profound perivascular mononuclear leukocytic
infiltration, as well as neointimal hyperplasia characteristic of
transplant arteriosclerosis (Figure 3a and b, right panels); these
findings were not observed in arteries of the isografts (Figure
3a and b, left panels). Immunophenotyping revealed that the
perivascular leukocytic infiltrate is mainly composed of
macrophages (CD11bþ ) and cytotoxic CD8þ T cells
(Supplementary Figure S1 online). Neointimal hyperplasia
was quantified in intrarenal arteries and was higher (P-value
o0.05) in the allografts at 8 and 12 weeks post transplantation
compared with isografts (Figure 3c). Applying the Banff
schema used for human kidney allografts, the vascular lesions
in all allografts at 12 weeks demonstrated neointima forma-
tion, significant arterial intimal fibrosis, and mononuclear
cell infiltration consistent with Banff grade 3 acute cellular
rejection, as well as evidence of chronic active T-cell–mediated
rejection (chronic allograft arteriopathy). Furthermore, there
was moderate (grade II) interstitial fibrosis and tubular
atrophy in the cortical area of the allograft recipients.
In this study, we report a feasible and reproducible model
of mouse kidney transplantation with consistent perivascular
inflammation and transplant arteriosclerosis. C57BL/6J (H-2b)
recipients received a kidney either from a Balb/cJ mouse
(H-2d; allograft) or from a littermate (isograft). This reprodu-
cibility is based on several quantitative measures including
survival data (Figure 1a), assessment of renal function (Figure
1b), proteinuria (Figure 1c), and histological changes (Figures
2a–c and 3a–c). Each of these criteria was quantified as
described in the methods and statistical significance. All the
allograft recipients (100%) that were evaluated at the 8-and
12-week time point displayed significant vascular neointimal
inflammation.
A hallmark lesion of long-term graft loss particularly in
solid organs such as the kidney is transplant arteriosclerosis
affecting intrarenal blood vessels. Although specific combina-
tions of rat strains are able to reproduce the classic lesion of
transplant arteriosclerosis with fibrointimal hyperplasia,13
mouse models have not been successful owing to variable
outcomes.14 The model described in this work showing
significant intrarenal vascular lesions offers an opportunity
for further mechanistic studies to uncover the pathogenesis
of this lesion and explore potential therapies. The factors
contributing to the development of the vascular lesions seen
in this model remain to be determined. It is possible that
administration of cyclosporine contributed to the vascular
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Figure 1 | Survival and renal function in allograft and isograft
recipients. (a) Survival rate was monitored after transplantation
for 12 weeks. (b) Serum was separated from blood that was
collected via retro-orbital puncture, and serum creatinine was
determined by LC-MS/MS at the indicated time points (n¼ 7/
group, *Po0.05). (c) Urine was collected at the time of killing,
and urinary albumin and creatinine were determined. Data are
represented as urinary albumin/creatinine ratio (n¼ 7/group,
*Po0.01).
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lesions in the allografts, although isografts received similar doses
of cyclosporine and did not develop any vascular pathology.
It is interesting to note that the blood vessels with marked
neointimal hyperplasia also had significant mononuclear
infiltration (mainly composed of macrophages (CD11bþ )
and cytotoxic CD8þ T cells), corroborating previous find-
ings15–17 and suggesting that vascular inflammation may be
linked to the development of neointimal hyperplasia.
In summary, we report a mouse model of renal
transplantation between C57BL/6J (H-2b) and mismatched
Balb/cJ mouse donor (H-2d; allograft) with high reproduci-
bility and low variability. The findings of vascular lesions of
transplant arteriosclerosis in this model would allow the study
of pathways involved and hence provide a tool to facilitate
translational studies to enhance long-term graft survival.
KIDNEY TRANSPLANTATION
The study protocol was approved by the Institutional Animal
Care and Use Committee at the University of Alabama at
Birmingham and performed in accordance with the NIH
Guide for the Care and Use of Laboratory Animals.
Vascularized, orthotopic kidney transplants were performed
in mice as previously described.18,19 Briefly, donor and
recipient male mice weighing between 20 and 25 g were
anesthetized with isoflurane, and the donor kidney, ureter,
and bladder were harvested en bloc, including the renal
artery with a small aortic cuff and the renal vein with a small
caval cuff (Supplementary Video files S1 and S2 online, and
Figure 4). The arterial and venous cuffs attached to the donor
organ were anastomosed to the recipient abdominal aorta
and vena cava, respectively, below the level of the native renal
vessels. Donor and recipient bladders were attached dome to
dome. The left native kidney was removed at the time of
transplant, and the right native kidney was removed through
a flank incision 1 week later; care was taken to preserve the
recipient adrenal glands with their normal blood supply. Two
experimental groups were evaluated. In the isograft group
C57BL/6J (H-2b) recipients received a kidney from a
littermate and in the allograft group C57BL/6J (H-2b)
recipients received a kidney from a completely mismatched
Balb/cJ mouse (H-2d; allograft). Both allograft and isograft
recipients received cyclosporine at a dose of 10mg/kg daily
subcutaneously for 14 days to prevent acute rejection.
MEASUREMENT OF KIDNEY TRANSPLANT FUNCTION
Renal function was determined by collecting retro-orbital
blood at the indicated time points. Serum creatinine levels
were measured as previously described using LC-MS/MS.20
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Figure 2 | Increased renal interstitial fibrosis in the allograft recipient group. (a) Histological analysis of renal isografts (left panels) and
allografts (right panels). Isografts demonstrate preserved architecture (upper panels), normal intrarenal arteries (middle panels), and less
fibrosis (lower panels). (b) Higher magnification of Masson trichrome staining demonstrates the collagen deposition in the cortex (upper
panels) and medulla (lower panels). (c) Ten random fields (five cortical and five medullary) were selected from each graft recipient for digital
quantification of collagen deposition (n¼ 7/group, *Po0.05). Bar¼ 100mm. H&E, hematoxylin and eosin.
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Urine was collected via bladder puncture at the time of
killing, and the albumin/creatinine ratio was determined as
described previously.21
HISTOLOGY
For determination of histological changes, kidney grafts were
isolated and harvested, fixed in 10% neutral buffered
formalin (Fisher Scientific, Pittsburgh, PA), and embedded
in paraffin. Five-micrometer serial sections were stained
using hematoxylin and eosin, Masson trichrome, periodic
acid–Schiff, and elastin staining protocols. Histomorpho-
metric analyses were performed on images acquired with a
Digital Module R Leica microscope (Leica, Bannockburn, IL)
and IMAGE PRO software (Media Cybernetics, Silver Spring,
MD). Neointimal hyperplasia in intrarenal arteries was calcu-
lated using the formula [(neoinitmal hyperplasia arealumen
area)/neointimal hyperplasia area] 100 and expressed as a
percentage. The area of collagen deposition, stained blue by
Masson trichrome staining, was measured by color image
analysis software from ten random images (five cortical and
five medullary images) from each graft recipient. Five-
micrometer frozen sections from five different allograft
recipients were used for Immunofluorescence staining of
CD11b (Abcam, Cambridge, MA), CD4, and CD8 (Santa
Cruz Biotechnology, Santa Cruz, CA).
STATISTICAL ANALYSIS
Data were represented as mean±s.e.. One-way analysis of
variance followed by the Holm–Sidak or Tukey–Kramer test
was performed for multiple-group comparisons. Student’s
t-test was used for comparison between two groups. Po0.05
was considered significant.
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Figure 3 |Perivascular leukocytic infiltrate and neointimal hyperplasia in allografts. (a) Periodic acid–Schiff (PAS) staining of renal
allografts depicts significant perivascular mononuclear cell infiltrates and extensive intrarenal arterial neointimal hyperplasia. (b) A
representative image of Masson trichrome staining performed on the kidney showing severe neointimal hyperplasia and luminal
obliteration that is exclusively found in the allografts (upper panels). Elastin staining was performed (middle panels) to demonstrate the
extent of neointimal hyperplasia. Higher-magnification images of the neointimal layer (vertical bar) in the respective groups (lower panels).
(c) Quantification of neointimal hyperplasia as described in the methods. *Po0.05. Bar¼ 100mm.
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SUPPLEMENTARY MATERIAL
Figure S1. Immunofluorescence staining of CD11b (left) and CD8
(right) demonstrates that the majority of perivascular infiltrates are
composed of macrophages and CD8þ T cells in allografts.
Video file S1. The clip demonstrates the donor kidney along with the
ureter and bladder before anastomosis to the recipient.
Video file S2. The clip shows the cross clamp removal following
anastomosis. Note the change in color in the graft that manifests full
reperfusion.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
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Figure 4 |Mouse orthotopic kidney transplantation.
(a) Transplanted kidney a few seconds following cross-clamp
removal. Note the patchy red areas indicating restoration of
normal blood flow. (b) The same kidney after complete
reperfusion. The upper suture line on the abdominal aorta can
also be seen (arrow). (c) The forceps in the lower right corner
indicates the suture line where the donor and recipient bladders
are joined dome to dome. (d) Gross morphology of a kidney
allograft and bladder at 8 weeks after transplantation. Note the
presence of urine in the bladder.
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